miRNA biogenesis: Biological impact in the development of cancer

Cancer Biology and Therapy

Volumn 15, Issue 11, 2014, Pages 1444-1455

  Romero Cordoba, Sandra L ^a   Salido Guadarrama, Ivan ^a   Rodriguez Dorantes, Mauricio ^a   Hidalgo Miranda, Alfredo ^a  

^a INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

Cancer; Cellular signaling; miRNA biogenesis

Indexed keywords

ARGONAUTE 2 PROTEIN; ARGONAUTE PROTEIN; DICER; DNA DIRECTED RNA POLYMERASE III; DROSHA PROTEIN; EXPORTIN 5; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MICRORNA; MICRORNA 1; MICRORNA 145; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 192; MICRORNA 193; MICRORNA 194; MICRORNA 195; MICRORNA 199A; MICRORNA 200; MICRORNA 335; MICRORNA 34; MYC PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; KARYOPHERIN;

BIOGENESIS; BREAST CANCER; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CANCER; CUTANEOUS MELANOMA; CYTOPLASM; DOWN REGULATION; ENZYME METABOLISM; EPIGENETICS; GALLBLADDER CARCINOMA; GENE EXPRESSION; GENE LOCUS; HUMAN; IMMUNOPRECIPITATION; MOUTH SQUAMOUS CELL CARCINOMA; NASOPHARYNX CANCER; NON SMALL CELL LUNG CANCER; NONHUMAN; OVARY CANCER; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVIEW; RNA PROCESSING; RNA SPLICING; RNA STRUCTURE; RNA TRANSPORT; SIGNAL TRANSDUCTION; SOFT TISSUE SARCOMA; T CELL LYMPHOMA; TRANSCRIPTION REGULATION; TRIPLE NEGATIVE BREAST CANCER; ANIMAL; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MORTALITY; NEOPLASM; PATHOLOGY; PROGNOSIS;

ANIMALS; ARGONAUTE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KARYOPHERINS; MICRORNAS; NEOPLASMS; PROGNOSIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84918587159     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/15384047.2014.955442     Document Type: Review

References (148)

1. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009; 60:167-79; PMID: 19630570; http://dx.doi.org/10.1146/annurev.med.59.053006.104707
2. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-69; PMID:16557279; http://dx.doi.org/10.1038/nrc1840
3. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103:2257-61; PMID: 16461460; http://dx.doi.org/10.1073/pnas.0510565103
4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-8; PMID: 15944708; http://dx.doi.org/10.1038/nature03702.
5. Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012; 482:347-55; PMID:22337054; http://dx.doi.org/10.1038/nature10888
6. Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T, Margalit H. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 2005; 33:2697-706; PMID:15891114; http://dx.doi.org/10.1093/nar/gki567
7. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. Embo J 2004; 23:4051-60; PMID: 15372072; http://dx.doi.org/10.1038/sj.emboj.7600385
8. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006; 13:1097-101.
9. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. Rna 2004; 10:1957-66; PMID:15525708; http://dx.doi.org/10.1261/rna.7135204
10. Blaszczyk J, Tropea JE, Bubunenko M, Routzahn KM, Waugh DS, Court DL, Ji X. Crystallographic and modeling studies of RNase III suggest a mechanism for double-stranded RNA cleavage. Structure 2001; 9:1225-36; PMID:11738048; http://dx.doi.org/10.1016/S0969-2126(01)00685-2
11. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004; 18:3016-27; PMID:15574589; http://dx.doi.org/10.1101/gad.1262504
12. Han J, Pedersen JS, Kwon SC, Belair CD, Kim YK, Yeom KH, Yang WY, Haussler D, Blelloch R, Kim VN. Posttranscriptional crossregulation between Drosha and DGCR8. Cell 2009; 136:75-84
13. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, Sohn SY, Cho Y, Zhang BT, Kim VN. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006; 125:887-901; PMID:16751099; http://dx.doi.org/10.1016/j.cell.2006.03.043
14. Morlando M, Ballarino M, Gromak N, Pagano F, Bozzoni I, Proudfoot NJ. Primary microRNA transcripts are processed co-transcriptionally. Nat Struct Mol Biol 2008; 15:902-9; PMID:19172742; http://dx.doi.org/10.1038/nsmb.1475
15. Zeng Y, Cullen BR. Sequence requirements for micro RNA processing and function in human cells. Rna 2003; 9:112-23; PMID:12554881; http://dx.doi.org/10.1261/rna.2780503
16. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425:415-9.
17. Berezikov E, Chung WJ, Willis J, Cuppen E, Lai EC. Mammalian mirtron genes. Mol Cell 2007; 28:328-36; PMID:17964270; http://dx.doi.org/10.1016/j.molcel.2007.09.028
18. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003; 17:3011-6; PMID:14681208; http://dx.doi.org/10.1101/gad.1158803
19. Zeng Y, Cullen BR. Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Res 2004; 32:4776-85; PMID: 15356295; http://dx.doi.org/10.1093/nar/gkh824
20. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005; 123:631-40; PMID:16271387; http://dx.doi.org/10.1016/j.cell.2005.10.022
21. Feng Y, Zhang X, Graves P, Zeng Y. A comprehensive analysis of precursor microRNA cleavage by human Dicer. Rna 2012; 18:2083-92; PMID: 22984192; http://dx.doi.org/10.1261/rna.033688.112
22. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436:740-4; PMID:15973356; http://dx.doi.org/10.1038/nature03868
23. Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN. The role of PACT in the RNA silencing pathway. Embo J 2006; 25:522-32; PMID:16424907; http://dx.doi.org/10.1038/sj.emboj.7600942
24. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV, Hannon GJ. Dicer is essential for mouse development. Nat Genet 2003; 35:215-7.
25. Davis TH, Cuellar TL, Koch SM, Barker AJ, Harfe BD, McManus MT, Ullian EM. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J Neurosci 2008; 28:4322-30; PMID: 18434510; http://dx.doi.org/10.1523/JNEUROSCI.4815-07.2008
26. Maniataki E, Mourelatos Z. A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev 2005; 19:2979-90; PMID: 16357216; http://dx.doi.org/10.1101/gad.1384005
27. Daschkey S, Rottgers S, Giri A, Bradtke J, Teigler-Schlegel A, Meister G, Borkhardt A, Landgraf P. MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. PloS One 2013; 8:e56334; PMID:23418555
28. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115:199-208; PMID:14567917; http://dx.doi.org/10.1016/S0092-8674(03)00759-1
29. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115:209-16; PMID:14567918; http://dx.doi.org/10.1016/S0092-8674(03)00801-8
30. Romero-Cordoba S, Rodriguez-Cuevas S, Rebollar-Vega R, Quintanar-Jurado V, Maffuz-Aziz A, Jimenez-Sanchez G, Bautista-Pina V, Arellano-Llamas R, Hidalgo-Miranda A. Identification and pathway analysis of microRNAs with no previous involvement in breast cancer. PLoS One 2012; 7:e31904.
31. Marco A, Macpherson JI, Ronshaugen M, Griffiths-Jones S. MicroRNAs from the same precursor have different targeting properties. Silence 2012; 3:8; PMID:23016695; http://dx.doi.org/10.1186/1758-907X-3-8
32. Hutvagner G, Simard MJ. Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol 2008; 9:22-32; PMID:18073770; http://dx.doi.org/10.1038/nrm2321
33. Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 2008; 132:9-14; PMID:18191211; http://dx.doi.org/10.1016/j.cell.2007.12.024
34. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 2005; 7:719-23.
35. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447:1130-4; PMID: 17554337; http://dx.doi.org/10.1038/nature05939
36. Davis BN, Hata A. Regulation of MicroRNA Biogenesis: A miRiad of mechanisms. Cell Commun Signal 2009; 7:18; PMID:19664273; http://dx.doi.org/10.1186/1478-811X-7-18
37. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009; 284:3728-38; PMID:19088079; http://dx.doi.org/10.1074/jbc.M808788200
38. Shao M, Rossi S, Chelladurai B, Shimizu M, Ntukogu O, Ivan M, Calin GA, Matei D. PDGF induced microRNA alterations in cancer cells. Nucleic Acids Res 2011; 39:4035-47; PMID: 21266476; http://dx.doi.org/10.1093/nar/gkq1305
39. Butz H, Racz K, Hunyady L, Patocs A. Crosstalk between TGF-beta signaling and the microRNA machinery. Trends Pharmacol Sci 2012; 33:382-93; PMID:22613783; http://dx.doi.org/10.1016/j.tips.2012.04.003
40. Bui TV, Mendell JT. Myc: Maestro of MicroRNAs. Genes Cancer 2010; 1:568-75; PMID: 20882107; http://dx.doi.org/10.1177/1947601910377491
41. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40:43-50; PMID:18066065; http://dx.doi.org/10.1038/ng.2007.30
42. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435:839-43; PMID: 15944709; http://dx.doi.org/10.1038/nature03677
43. Loven J, Zinin N, Wahlstrom T, Muller I, Brodin P, Fredlund E, Ribacke U, Pivarcsi A, Pahlman S, Henriksson M. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Proc Natl Acad Sci U S A 2010; 107:1553-8; PMID:20080637; http://dx.doi.org/10.1073/pnas.0913517107
44. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435:828-33; PMID:15944707
45. Yu G, Tang JQ, Tian ML, Li H, Wang X, Wu T, Zhu J, Huang SJ, Wan YL. Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer. J Surg Oncol 2012; 106:232-7; PMID:22065543
46. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL, Rajewsky K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9:405-14; PMID: 18327259
47. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006; 38:1060-5; PMID:16878133; http://dx.doi.org/10.1038/ng1855
48. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12:247-56.
49. Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, Ambesi-Impiombato A, Califano A, Migliazza A, Bhagat G, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17:28-40; PMID:20060366
50. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond CK, Dai H, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007; 27:2240-52.
51. Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, Dobbyn HC, Elia A, Kress TR, Dickens M, Clemens MJ, et al. p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci U S A 2010; 107:5375-80.
52. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, Jung J, Gao P, Dang CV, Beer MA, et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A 2009; 106:3384-9; PMID:19211792; http://dx.doi.org/10.1073/pnas.0808300106
53. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008; 105:13556-61; PMID:18768788; http://dx.doi.org/10.1073/pnas.0803055105
54. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A, San-chez- Cespedes M, Git A, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007; 67:1424-9; PMID: 17308079; http://dx.doi.org/10.1158/0008-5472.CAN-06-4218
55. Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 2010; 29:6390-401; PMID:20802525; http://dx.doi.org/10.1038/onc.2010.361
56. Urdinguio RG, Fernandez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M, Liu CG, Croce CM, Calin GA, Esteller M. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010; 5:656-63; PMID: 20716963; http://dx.doi.org/10.4161/epi.5.7.13055
57. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6:14; PMID:18577219; http://dx.doi.org/10.1186/1741-7015-6-14
58. Agirre X, Vilas-Zornoza A, Jimenez-Velasco A, Martin-Subero JI, Cordeu L, Garate L, San Jose-Eneriz E, Abizanda G, Rodriguez-Otero P, Fortes P, et al. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res 2009; 69:4443-53; PMID: 19435910; http://dx.doi.org/10.1158/0008-5472.CAN-08-4025
59. Pang RT, Leung CO, Ye TM, Liu W, Chiu PC, Lam KK, Lee KF, Yeung WS. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010; 31:1037-44; PMID:20351093; http://dx.doi.org/10.1093/carcin/bgq066
60. Majid S, Dar AA, Saini S, Arora S, Shahryari V, Zaman MS, Chang I, Yamamura S, Tanaka Y, Deng G, et al. MicroRNA-23b represses proto-oncogene Src kinase, functions as a methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res 2012; 72:6435-46; PMID:23074286
61. Suh SO, Chen Y, Zaman MS, Hirata H, Yamamura S, Shahryari V, Liu J, Tabatabai ZL, Kakar S, Deng G, et al. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis 2011; 32:772-8; PMID:21349819; http://dx.doi.org/10.1093/carcin/bgr036
62. Gao XN, Lin J, Li YH, Gao L, Wang XR, Wang W, Kang HY, Yan GT, Wang LL, Yu L. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Oncogene 2011; 30:3416-28; PMID: 21399664; http://dx.doi.org/10.1038/onc.2011.62
63. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010; 11:136-46; PMID:20022810; http://dx.doi.org/10.1016/S1470-2045(09)70343-2
64. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451:147-52.
65. Chen WS, Leung CM, Pan HW, Hu LY, Li SC, Ho MR, Tsai KW. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. Oncol Rep 2012; 28:1069-76; PMID:22766685
66. Davalos V, Moutinho C, Villanueva A, Boque R, Silva P, Carneiro F, Esteller M. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 2012; 31:2062-74; PMID:21874049; http://dx.doi.org/10.1038/onc.2011.383
67. Goel A, Boland CR. Epigenetics of Colorectal Cancer. Gastroenterology 2012; 143; 1442-60; PMID: 23000599 http://dx.doi.org/10.1053/j.gastro.2012.09.032
68. Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L, Haines DC, Basik M, Mai P, Poggi E, et al. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med 2011; 17:1275-82; PMID:21946536; http://dx.doi.org/10.1038/nm.2459
69. Soto-Reyes E, Gonzalez-Barrios R, Cisneros-Soberanis F, Herrera-Goepfert R, Perez V, Cantu D, Prada D, Castro C, Recillas-Targa F, Herrera LA. Disruption of CTCF at the miR-125b1 locus in gynecological cancers. BMC Cancer 2012; 12:40; PMID: 22277129; http://dx.doi.org/10.1186/1471-2407-12-40
70. Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, Liao DZ, Huang MY, Hou JH, Wu QL, Zeng MS, et al. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res 2011; 71:3552-62; PMID:21444677; http://dx.doi.org/10.1158/0008-5472.CAN-10-2435
71. Siomi H, Siomi MC. Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 2010; 38:323-32; PMID:20471939; http://dx.doi.org/10.1016/j.molcel.2010.03.013
72. Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep 2007; 8:763-9; PMID: 17599088; http://dx.doi.org/10.1038/sj.embor.7401011
73. Choudhury Y, Tay FC, Lam DH, Sandanaraj E, Tang C, Ang BT, Wang S. Attenuated adenosine-to-inosine editing of microRNA-376a∗ promotes invasiveness of glioblastoma cells. J Clin Invest 2012; 122:4059-76; PMID:23093778; http://dx.doi.org/10.1172/JCI62925
74. Shiohama A, Sasaki T, Noda S, Minoshima S, Shimizu N. Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. Exp Cell Res 2007; 313:4196-207; PMID:17765891; http://dx.doi.org/10.1016/j.yexcr.2007.07.020
75. Fuller-Pace FV, Ali S. The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): novel transcriptional co-regulators. Biochem Soc Trans 2008; 36:609-12; PMID:18631126; http://dx.doi.org/10.1042/BST0360609
76. Fuller-Pace FV. DExD/H box RNA helicases: multi-functional proteins with important roles in transcriptional regulation. Nucleic Acids Res 2006; 34:4206-15; PMID:16935882; http://dx.doi.org/10.1093/nar/gkl460
77. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008; 454:56-61; PMID:18548003; http://dx.doi.org/10.1038/nature07086
78. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 2010; 39:373-84; PMID:20705240; http://dx.doi.org/10.1016/j.molcel.2010.07.011
79. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ. MicroRNA-155 is regulated by the transforming growth factor β/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 2008; 28:6773-84; PMID:18794355; http://dx.doi.org/10.1128/MCB.00941-08
80. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature 2009; 460:529-33; PMID:19626115; http://dx.doi.org/10.1038/nature08199
81. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 2012; 12:613-26; PMID:22898542; http://dx.doi.org/10.1038/nrc3318
82. Zhu H, Dougherty U, Robinson V, Mustafi R, Pekow J, Kupfer S, Li YC, Hart J, Goss K, Fichera A, et al. EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res 2011; 9:960-75; PMID:21653642; http://dx.doi.org/10.1158/1541-7786.MCR-10-0531
83. Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Jr., Hofmainster C, Alder H, et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 2010; 18:367-81.
84. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, et al. p53 regulates epithelial-mesenchymal transition throughmicroRNAs targeting ZEB1 and ZEB2. J Exp Med 2011; 208:875-83; PMID:21518799; http://dx.doi.org/10.1084/jem.20110235
85. Leveille N, Elkon R, Davalos V, Manoharan V, Hollingworth D, Oude Vrielink J, le Sage C, Melo CA, Horlings HM, Wesseling J, et al. Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nat Commun 2011; 2:513; PMID:22027593; http://dx.doi.org/10.1038/ncomms1519
86. Kawai S, Amano A. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. J Cell Biol 2012; 197:201-8; PMID:22492723; http://dx.doi.org/10.1083/jcb.201110008
87. Wilson MD, Wang D, Wagner R, Breyssens H, Gertsenstein M, Lobe C, Lu X, Nagy A, Burke RD, Koop BF, et al. ARS2 is a conserved eukaryotic gene essential for early mammalian development. Mol Cell Biol 2008; 28:1503-14; PMID:18086880; http://dx.doi.org/10.1128/MCB.01565-07
88. Gruber JJ, Zatechka DS, Sabin LR, Yong J, Lum JJ, Kong M, Zong WX, Zhang Z, Lau CK, Rawlings J, et al. Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation. Cell 2009; 138:328-39; PMID:19632182; http://dx.doi.org/10.1016/j.cell.2009.04.046
89. Sabin LR, Zhou R, Gruber JJ, Lukinova N, Bambina S, Berman A, Lau CK, Thompson CB, Cherry S. Ars2 regulates both miRNA- and siRNA-dependent silencing and suppresses RNA virus infection in Drosophila. Cell 2009; 138:340-51.
90. Haselmann V, Kurz A, Bertsch U, Hubner S, Olempska-Muller M, Fritsch J, Hasler R, Pickl A, Fritsche H, Annewanter F, et al. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells. Gastroenterology 2014; 146:278-90; PMID:24120475; http://dx.doi.org/10.1053/j.gastro.2013.10.009
91. Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirsch J, Jacoby E, Eyal E, Rivkin L, Prieto VG, et al. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest 2013; 123:2703-18; PMID:23728176; http://dx.doi.org/10.1172/JCI62980
92. Hong S, Noh H, Chen H, Padia R, Pan ZK, Su SB, Jing Q, Ding HF, Huang S. Signaling by p38 MAPK stimulates nuclear localization of the microprocessor component p68 for processing of selected primary microRNAs. Sci Signaling 2013; 6:ra16; PMID:23482664
93. Paris O, Ferraro L, Grober OM, Ravo M, De Filippo MR, Giurato G, Nassa G, Tarallo R, Cantarella C, Rizzo F, et al. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene 2012; 31:4196-206.
94. Kong X, Xu X, Yan Y, Guo F, Li J, Hu Y, Zhou H, Xun Q. Estrogen Regulates the Tumour Suppressor MiRNA-30c and Its Target Gene, MTA-1, in Endometrial Cancer. PloS One 2014; 9:e90810; PMID:24595016
95. Fletcher CE, Dart DA, Sita-Lumsden A, Cheng H, Rennie PS, Bevan CL. Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer. Hum Mol Genet 2012; 21:3112-27.
96. Michlewski G, Guil S, Semple CA, Caceres JF. Post-transcriptional regulation of miRNAs harboring conserved terminal loops. Mol Cell 2008; 32:383-93; PMID:18995836; http://dx.doi.org/10.1016/j.molcel.2008.10.013
97. Trabucchi M, Briata P, Garcia-Mayoral M, Haase AD, Filipowicz W, Ramos A, Gherzi R, Rosenfeld MG. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009; 459:1010-4.
98. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, O'Sullivan M, Lu J, Phillips LA, Lockhart VL, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009; 41:843-8.
99. Heo I, Joo C, Kim YK, Ha M, Yoon MJ, Cho J, Yeom KH, Han J, Kim VN. TUT4 in concert with Lin28 suppresses microRNA biogenesis through premicroRNA uridylation. Cell 2009; 138:696-708; PMID:19703396; http://dx.doi.org/10.1016/j.cell.2009.08.002
100. Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl EE, Nitsch R, Wulczyn FG. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol 2008; 10:987-93; PMID:18604195; http://dx.doi.org/10.1038/ncb1759
101. Chen AX, Yu KD, Fan L, Li JY, Yang C, Huang AJ, Shao ZM. Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. PLoS Genet 2011; 7: e189818992259; PMID:21912531
102. Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya G, et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 2010; 18:303-15; PMID:20951941; http://dx.doi.org/10.1016/j.ccr.2010.09.007
103. Melo SA, Esteller M. A precursor microRNA in a cancer cell nucleus: get me out of here! Cell Cycle 2011; 10:922-5; PMID:21346411
104. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282:14328-36; PMID:17363372; http://dx.doi.org/10.1074/jbc.M611393200
105. Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, Whelan AJ, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009; 325:965.
106. Davalos V, Esteller M. Rolling the dice to discover the role of DICER in tumorigenesis. Cancer Cell 2012; 21:717-9; PMID:22698397; http://dx.doi.org/10.1016/j.ccr.2012.05.030
107. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41:365-70; PMID:19219043; http://dx.doi.org/10.1038/ng.317
108. Newman MA, Thomson JM, Hammond SM. Lin- 28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. Rna 2008; 14:1539-49.
109. Heo I, Ha M, Lim J, Yoon MJ, Park JE, Kwon SC, Chang H, Kim VN. Mono-uridylation of pre-microRNA as a key step in the biogenesis of group II let-7 microRNAs. Cell 2012; 151:521-32; PMID:23063654; http://dx.doi.org/10.1016/j.cell.2012.09.022
110. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL, Leung ML, El-Naggar A, Creighton CJ, Suraokar MB, et al. TAp63 suppresses metastasis through coordinate regulation of dicer and miRNAs. Nature 2010; 467:986-90.
111. Muller PA, Trinidad AG, Caswell PT, Norman JC, Vousden KH. Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype. J Biol Chem 2014; 289:122-32; PMID:24220032; http://dx.doi.org/10.1074/jbc.M113.502138
112. Dewi DL, Ishii H, Haraguchi N, Nishikawa S, Kano Y, Fukusumi T, Ozaki M, Saito T, Sakai D, Satoh T, et al. Dicer 1, ribonuclease type III modulates a reprogramming effect in colorectal cancer cells. Int J Mol Med 2012; 29:1060-4; PMID:22446887
113. Daniels SM, Gatignol A. The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer. Microbiol Mol Biol Rev 2012; 76:652-66; PMID:22933564; http://dx.doi.org/10.1128/MMBR.00012-12
114. Xhemalce B, Robson SC, Kouzarides T. Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell 2012; 151:278-88.
115. Jafarnejad SM, Sjoestroem C, Martinka M, Li G. Expression of the RNase III enzyme DROSHA is reduced during progression of human cutaneous melanoma. Mod Pathol: Official JU S Canada Acad Pathol, Inc 2013; 26:902-10; PMID:23370771
116. Diaz-Garcia CV, Agudo-Lopez A, Perez C, Lopez-Martin JA, Rodriguez-Peralto JL, de Castro J, Cortijo A, Martinez-Villanueva M, Iglesias L, Garcia-Carbonero R, et al. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification. Carcinogenesis 2013; 34:1031-8; PMID:23349018; http://dx.doi.org/10.1093/carcin/bgt022
117. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S, Mitsudomi T, et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005; 96:111-5; PMID:15723655; http://dx.doi.org/10.1111/j.1349-7006.2005.00015.x
118. Caffrey E, Ingoldsby H, Wall D, Webber M, Dinneen K, Murillo LS, Inderhaug C, Newell J, Gupta S, Callagy G. Prognostic significance of deregulated dicer expression in breast cancer. PloS One 2013; 8:e83724.
119. Kawahara K, Nakayama H, Nagata M, Yoshida R, Hirosue A, Tanaka T, Nakagawa Y, Matsuoka Y, Kojima T, Takamune Y, et al. A low dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma. J Oral PatholMed: Official Publ Int Assoc Oral Pathologists Am Acad Oral Pathol 2013; 43:350-6; PMID:24325353; http://dx.doi.org/10.1111/jop.12140
120. Vincenzi B, Zoccoli A, Schiavon G, Iuliani M, Pantano F, Dell'aquila E, Ratta R, Muda AO, Perrone G, Brunelli C, et al. Dicer and Drosha expression and response to bevacizumab-based therapy in advanced colorectal cancer patients. Eur J Cancer 2013; 49:1501-8; PMID:23266047; http://dx.doi.org/10.1016/j.ejca.2012.11.014
121. Papachristou DJ, Rao UN, Korpetinou A, Giannopoulou E, Sklirou E, Kontogeorgakos V, Kalofonos HP. Prognostic significance of Dicer cellular levels in soft tissue sarcomas. Cancer Invest 2012; 30:172-9; PMID:22149178; http://dx.doi.org/10.3109/07357907.2011.633293
122. Zhu DX, Fan L, Lu RN, Fang C, Shen WY, Zou ZJ, Wang YH, Zhu HY, Miao KR, Liu P, et al. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia. Cancer Sci 2012; 103:875-81.
123. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008; 359:2641-50.
124. Shu GS, Yang ZL, Liu DC. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Pathol Res Pract 2012; 208:392-7; PMID:22658478; http://dx.doi.org/10.1016/j.prp.2012.05.001
125. Passon N, Gerometta A, Puppin C, Lavarone E, Puglisi F, Tell G, Di Loreto C, Damante G. Expression of Dicer and Drosha in triple-negative breast cancer. J Clin Pathol 2012; 65:320-6; PMID:22259182; http://dx.doi.org/10.1136/jclinpath-2011-200496
126. Guo X, Liao Q, Chen P, Li X, Xiong W, Ma J, Luo Z, Tang H, Deng M, Zheng Y, et al. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2012; 138:49-56; PMID:21953080
127. Li X, Tian X, Zhang B, Chen J. Polymorphisms in microRNA-related genes are associated with survival of patients with T-Cell lymphoma. Oncologist 2014; 19:243-9; PMID:24563077; http://dx.doi.org/10.1634/theoncologist.2013-0370
128. Diederichs S, Haber DA. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 2007; 131:1097-108; PMID:18083100; http://dx.doi.org/10.1016/j.cell.2007.10.032
129. Adams BD, Claffey KP, White BA. Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology 2009; 150:14-23; PMID:18787018; http://dx.doi.org/10.1210/en.2008-0984
130. Wu C, So J, Davis-Dusenbery BN, Qi HH, Bloch DB, Shi Y, Lagna G, Hata A. Hypoxia potentiates microRNA-mediated gene silencing through post-translational modification of Argonaute2. Mol Cell Biol 2011; 31:4760-74; PMID:21969601; http://dx.doi.org/10.1128/MCB.05776-11
131. Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, Lim SO, Du Y, Wang Y, Chang WC, Chen CH, et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 2013; 497:383-7; PMID:23636329; http://dx.doi.org/10.1038/nature12080
132. Winter J, Diederichs S. Argonaute proteins regulate microRNA stability: IncreasedmicroRNA abundance by Argonaute proteins is due to microRNA stabilization. RNA Biol 2011; 8:1149-57; PMID:21941127; http://dx.doi.org/10.4161/rna.8.6.17665
133. Janas MM, Wang B, Harris AS, Aguiar M, Shaffer JM, Subrahmanyam YV, Behlke MA, Wucherpfennig KW, Gygi SP, Gagnon E, et al. Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins. Rna 2012; 18:2041-55.
134. Dueck A, Ziegler C, Eichner A, Berezikov E, Meister G. microRNAs associated with the different human Argonaute proteins. Nucleic Acids Res 2012; 40:9850-62; PMID:22844086; http://dx.doi.org/10.1093/nar/gks705
135. Winter J, Diederichs S. Argonaute-3 activates the let-7a passenger strand microRNA. RNA Biology 2013; 10:1631-43; PMID:24100239
136. Plante I, Ple H, Landry P, Gunaratne PH, Provost P. Modulation of microRNA activity by semi-microRNAs. Front Genet 2012; 3:99.
137. Zisoulis DG, Kai ZS, Chang RK, Pasquinelli AE. Autoregulation of microRNA biogenesis by let-7 and Argonaute. Nature 2012; 486:541-4; PMID:22722835
138. Juvvuna PK, Khandelia P, Lee LM, Makeyev EV. Argonaute identity defines the length of mature mammalian microRNAs. Nucleic Acids Res 2012; 40:6808-20; PMID:22505576; http://dx.doi.org/10.1093/nar/gks293
139. Wang T, Zang WQ, Li M, Wang N, Zheng YL, Zhao GQ. Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. DigDis Sci 2012; 58:706-14;PMID:23053883
140. Tian Y, Nan Y, Han L, Zhang A, Wang G, Jia Z, Hao J, Pu P, Zhong Y, Kang C. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. Int J Oncol 2012; 40:1105-12; PMID:22179124
141. Bitarte N, Bandres E, Boni V, Zarate R, Rodriguez J, Gonzalez-Huarriz M, Lopez I, Javier Sola J, Alonso MM, Fortes P, et al. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 2011; 29:1661-71; PMID:21948564; http://dx.doi.org/10.1002/stem.741
142. Yang JS, Maurin T, Lai EC. Functional parameters of Dicer-independent microRNA biogenesis. Rna 2012; 18:945-57; PMID:22461413; http://dx.doi.org/10.1261/rna.032938.112
143. Winter J, Link S, Witzigmann D, Hildenbrand C, Previti C, Diederichs S. Loop-miRs: active microRNAs generated from single-stranded loop regions. Nucleic Acids Res 2013; 41:5503-12; PMID:23580554; http://dx.doi.org/10.1093/nar/gkt251
144. Cloonan N, Wani S, Xu Q, Gu J, Lea K, Heater S, Barbacioru C, Steptoe AL, Martin HC, Nourbakhsh E, et al. MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol 2011; 12:R126; PMID:22208850
145. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495:384-8; PMID:23446346; http://dx.doi.org/10.1038/nature11993
146. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013; 495:333-8; PMID:23446348; http://dx.doi.org/10.1038/nature11928
147. Li ZF, Liang YM, Lau PN, Shen W, Wang DK, Cheung WT, Xue CJ, Poon LM, Lam YW. Dynamic localisation of mature microRNAs in Human nucleoli is influenced by exogenous genetic materials. PloS One 2013; 8:e70869; PMID:23940654
148. Redfern AD, Colley SM, Beveridge DJ, Ikeda N, Epis MR, LiX, Foulds CE, Stuart LM, BarkerA, RussellVJ, et al. RNA-induced silencing complex (RISC) Proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators. Proc Natl Acad Sci U S A 2013; 110:6536-41; PMID:23550157; http://dx.doi.org/10.1073/pnas.1301620110